Press-release for stocks published on today

Prices are updated after-hours

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

| 0.0% | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K

| 0.0% | O: 0.1% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| 0.0% | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| 0.0% | O: -0.82% H: 0.37% C: 0.17%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

| 0.97% | O: 0.77% H: 0.0% C: 0.0%
positive treatment global for

Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

| 0.0% | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K

| 0.0% | O: -5.26% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| 0.0% | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M

| 0.0% | O: -4.49% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K

| 0.0% | O: -0.29% H: 0.0% C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K

| 0.0% | O: 1.81% H: 0.0% C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K

| 0.0% | O: 0.06% H: 0.0% C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K

| 0.0% | O: -0.03% H: 0.0% C: 0.0%
AMRN | News | $0.8844 0.13% 0.12% 660K

| 0.0% | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M

| 0.0% | O: 0.27% H: 0.0% C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M

| 0.0% | O: 0.38% H: 0.0% C: 0.0%
OCX | News | $2.3 -6.31% -6.74% 41K

| 0.0% | O: -3.25% H: 0.0% C: 0.0%
biopharma

Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
XOMA | $25.11 -3.76% -3.9% 8.2K